Antidepressant medication treatment patterns in Asian patients with major depressive disorder

Antidepressant medication treatment patterns in Asian patients with major depressive disorder

Diego Novick,1 William Montgomery,2 Victoria Moneta,3 Xiaomei Peng,4 Roberto Brugnoli,5 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, Australia; 3Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Sp...

Full description

Bibliographic Details
Main Authors:	Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-03-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/antidepressant-medication-treatment-patterns-in-asian-patients-with-ma-peer-reviewed-article-PPA

Similar Items

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
by: Novick D, et al.
Published: (2013-05-01)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
by: Novick D, et al.
Published: (2017-10-01)

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting
by: Hong J, et al.
Published: (2015-10-01)

Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
by: Garcia-Toro Mauro, et al.
Published: (2012-09-01)

Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
by: Michael Leutner, et al.
Published: (2021-02-01)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
by: Huang J, et al.
Published: (2018-09-01)

Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
by: Fu, CHY, et al.
Published: (2024)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale.
by: Tzu-Yu Liu, et al.
Published: (2020-01-01)

Heartbeat evoked potential in major depressive disorder: Differential treatment prediction for antidepressant medication and rTMS
by: Lauren Zwienenberg, et al.
Published: (2021-11-01)

Assessing the beliefs about antidepressant medication and adherence to therapy in patients with major depressive disorders.
by: Samia Perwaiz Khan, et al.
Published: (2021-06-01)

Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
by: Nicolas A. Nuñez, et al.
Published: (2024-02-01)

Systematic review of pindolol augmentation of serotonergic antidepressant treatment for major depressive disorder
by: Whale, R, et al.
Published: (2005)

Should probiotics be administered as an adjunctive treatment along with antidepressants for major depressive disorder?
by: Haiqa Zulfiqar, et al.
Published: (2023-12-01)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
by: Andrea Fontana, et al.
Published: (2020-08-01)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01)

Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment
by: Samaneh Nemati, et al.
Published: (2020-01-01)

White matter integrity and medication response to antidepressants in major depressive disorder: a review of the literature
by: Giovanni Videtta, et al.
Published: (2024-02-01)

Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder
by: Yaping Wang, et al.
Published: (2023-08-01)

Electroencephalographic Network Topologies Predict Antidepressant Responses in Patients With Major Depressive Disorder
by: Yueheng Peng, et al.
Published: (2022-01-01)

An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
by: Spronk, D, et al.
Published: (2011)

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
by: Juncai Xin, et al.
Published: (2020-03-01)

Serotonergic antidepressants as predictors of depressive disorders treatment
by: Timotijević Ivana P., et al.
Published: (2014-01-01)

Prediction of Antidepressant Treatment Outcome Using Event-Related Potential in Patients with Major Depressive Disorder
by: Hyun Seo Lee, et al.
Published: (2020-05-01)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
by: K.H. Lee, et al.
Published: (2022-06-01)

Comparative change in P300 indices following antidepressant treatment in patients with major depressive disorder
by: Santosh L Wakode, et al.
Published: (2022-01-01)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
by: Lei Zhao, et al.
Published: (2022-01-01)

The influence of antidepressant and psychotherapy treatment adherence on future work leaves for patients with major depressive disorder
by: Fraser W. Gaspar, et al.
Published: (2020-06-01)

The effect of antidepressant treatment on white matter integrity in Major Depression
by: S. Tourjman, et al.
Published: (2022-06-01)

Restless Legs Syndrome: Associated with Major Depressive Disorder and Anxiety Disorder But Not with Antidepressant Use
by: Barış Yılbaş, et al.
Published: (2022-06-01)

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years
by: Stefanie Wagner, et al.
Published: (2020-05-01)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
by: Qiang Wang, et al.
Published: (2022-03-01)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
by: R. Song, et al.
Published: (2021-04-01)

Investigating the antidepressant effects of CBT-I in those with major depressive and insomnia disorders
by: Parky H. Lau, et al.
Published: (2022-07-01)

Addition of aerobic exercise to antidepressant drug monotherapy for major depressive disorder in adults
by: Camila Sanhueza Pastén, et al.
Published: (2022-01-01)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
by: James M Martinez, et al.
Published: (2015-05-01)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-07-01)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
by: Pedro L. Ballester, et al.
Published: (2021-01-01)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
by: Lin Yao, et al.
Published: (2020-12-01)

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
by: X.J. Wen, et al.
Published: (2014-07-01)

A study to identify unrecognized bipolar disorder in patients of major depressive disorder taking antidepressants
by: Kinjal Bhupendrasinh Chauhan, et al.
Published: (2022-12-01)